SCHEMBL7425520

SCHEMBL7425520

COC(=O)c1ccc2c(C=CC(C)=O)cn(Cc3ccccc3Cl)c2c1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.52
LMNA P02545 4/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
CNR2 P34972 2/20 0.50
SLC22A12 Q96S37 2/20 0.45
GAA P10253 1/20 0.44
PDE4A P27815 3/20 0.43
PDE4B Q07343 3/20 0.43
PDE4C Q08493 3/20 0.43
PDE4D Q08499 3/20 0.43
MAPK1 P28482 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TP53 P04637 1/20 0.42
ALDH1A1 P00352 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
CPT1A P50416 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7470611 1.00 MAPT (0.52) MAPTLMNASMN1; SMN2MEN1KMT2A
SCHEMBL7471953 0.90 SLC22A12 (0.49) MAPTLMNASMN1; SMN2MEN1KMT2A
SCHEMBL7425317 0.90 SLC22A12 (0.49) MAPTLMNASMN1; SMN2MEN1KMT2A
SCHEMBL7470357 0.89 MAPT (0.48) MAPTLMNASMN1; SMN2MEN1KMT2A
SCHEMBL7419442 0.89 MAPT (0.48) MAPTLMNASMN1; SMN2MEN1KMT2A
SCHEMBL7422870 0.88 MAPT (0.55) MAPTLMNASMN1; SMN2MEN1KMT2A
SCHEMBL8554268 0.81 MAPT (0.51) MAPTLMNASMN1; SMN2MEN1KMT2A
SCHEMBL7467136 0.80 TSHR (0.48) MAPTLMNASMN1; SMN2MEN1KMT2A
SCHEMBL7421750 0.77 CNR2 (0.45) MAPTLMNASMN1; SMN2MEN1KMT2A
SCHEMBL7427340 0.76 SMN1; SMN2 (0.54) MAPTLMNASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed